Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference
- PMID: 23323778
- DOI: 10.4155/tde.12.135
Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference
Abstract
The fourth annual European Paediatric Formulation Initiative (EuPFI) conference on Formulating Better Medicines for Children was held on 19-20 September 2012 at the Institute of Molecular Genetics Congress Centre, Prague, Czech Republic. The 2-day conference concentrated on the latest advances, challenges and opportunities for developing medicinal products and administration devices for pediatric use, both from European and US perspectives. It was aimed specifically at providing exposure to emerging practical applications, and for illustrating remedies utilized by pediatric drug-development teams to overcome hurdles faced in developing medicines for pediatric patients. The conference format included plenary talks, focus sessions on each of the EuPFI work streams (extemporaneous preparations, excipients, pediatric administration devices, taste masking and taste assessment, age-appropriate formulations), case studies, soapbox sessions and a parallel poster display. This conference report summarizes the keynote lectures and also gives a flavor of other presentations and posters from the conference.
Similar articles
-
European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.AAPS PharmSciTech. 2017 Feb;18(2):257-262. doi: 10.1208/s12249-016-0584-1. Epub 2016 Jul 15. AAPS PharmSciTech. 2017. PMID: 27422653 Review.
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.Clin Ther. 2008 Nov;30(11):2097-101. doi: 10.1016/j.clinthera.2008.11.017. Clin Ther. 2008. PMID: 19108797
-
Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.Adv Drug Deliv Rev. 2014 Jun;73:14-33. doi: 10.1016/j.addr.2014.02.012. Epub 2014 Mar 12. Adv Drug Deliv Rev. 2014. PMID: 24614069 Review.
-
Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.Eur J Pharm Biopharm. 2020 Aug;153:222-225. doi: 10.1016/j.ejpb.2020.06.012. Epub 2020 Jun 21. Eur J Pharm Biopharm. 2020. PMID: 32580052 Review.
-
European perspectives on pediatric formulations.Clin Ther. 2008 Nov;30(11):2146-54. doi: 10.1016/j.clinthera.2008.11.016. Clin Ther. 2008. PMID: 19108802
Cited by
-
Adverse drug reactions in hospitalized Colombian children.Colomb Med (Cali). 2016 Sep 30;47(3):142-147. Colomb Med (Cali). 2016. PMID: 27821893 Free PMC article.
-
Excipients in the Paediatric Population: A Review.Pharmaceutics. 2021 Mar 13;13(3):387. doi: 10.3390/pharmaceutics13030387. Pharmaceutics. 2021. PMID: 33805830 Free PMC article. Review.
-
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.Drug Des Devel Ther. 2015 Nov 20;9:5815-25. doi: 10.2147/DDDT.S86075. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26640367 Free PMC article.
-
Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations.Int J Gen Med. 2020 Nov 9;13:1051-1066. doi: 10.2147/IJGM.S280330. eCollection 2020. Int J Gen Med. 2020. PMID: 33204140 Free PMC article. Review.
-
Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.Ther Innov Regul Sci. 2024 Mar;58(2):316-335. doi: 10.1007/s43441-023-00596-0. Epub 2023 Dec 6. Ther Innov Regul Sci. 2024. PMID: 38055156
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical